Gamma hydroxybutyrate is not a GABA agonist

Progress in Neurobiology

Volumn 50, Issue 1, 1996, Pages 1-7

  Feigenbaum, Jeffery J ^a,c   Howard, Sherrel G ^b  

^a American Institute of Biotechnology   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Executive House ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; 4 HYDROXYBUTYRIC ACID; BACLOFEN; BICUCULLINE; FLUNITRAZEPAM; MUSCIMOL; PICROTOXIN; VALPROIC ACID; VIGABATRIN;

ANIMAL; ANIMAL EXPERIMENT; GABAERGIC SYSTEM; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030250038     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/0301-0082(96)00029-9     Document Type: Review

References (94)

1. Allekemets, L., Polevoi, L. G., Tsareva, T. A. and Zharkovskii, A. M. (1979) Dopaminergic component in the mechanism of action of gamma-aminobutyric acid derivatives and structural analogs. Farmakol. Toksikol. 42, 603-606.
2. Anden, N.-E. and Stock, G. (1973) Inhibitory effect of gamma-hydroxybutyric acid and gamma-amino-butyric acid on the dopamine cells in the substantia nigra. Naunyn Schmied. Arch. Pharmacol. 279, 89-92.
3. Anderson, R. A., Ritzmann, R. F. and Tabakoff, B. J. (1977) Formation of gamma-hydroxybutyrate in the brain. J Neurochem. 28, 633-639.
4. Ando, N., Gold, B. I., Bird, E. D. and Roth, R. H. (1979a) Regional brain levels of γ-hydroxybutyrate in Huntington's disease. J. Neurochem. 32, 617-622.
5. Ando, N., Simon, J. R. and Roth, R. H. (1979b) Inverse relationship between GABA and γ-hydroxybutyrate levels in the striatum of rat injected with kainic acid. J. Neurochem. 32, 623-625.
6. Artru, A., Steen, P. and Michenfelder, J. (1980) Gammahydroxybutyrate: Cerebral, metabolic, vascular and protective effects. J. Neurochem. 35, 1114-1119.
7. Beaumont, K., Chilton, W. S., Yamamura, H. I. and Enna, S. J. (1978) Muscimol binding in rat brain associated with GABA receptors. Brain Res. 148, 153-162.
8. + -dependent uptake system for γ-hydroxybutyrate in membrane vesicles prepared from brain. J. Neurochem. 38, 1570-1575.
9. B receptors. J. Neural Trans. Suppl. 35, 155-177.
10. 2-valproate in neonatal rat brain. Mol. Pharmacol. 43, 487-490.
11. Boschi, G., Launay, N. and Rips, R. (1991) Facilitation of amphetamine induced hypothermia in rats by GABA agonists and CCK-8. Brit. J. Pharmacol. 102, 986-990.
12. Bowman, W. and Rand, M. (1980) Textbook of Pharmacology, 2nd Edition, p. 274. Eds. W. Bowman and M. Rand. Blackwell, Oxford
13. Carlsson, A., Biswas, B. and Lindqvist, M. (1977) Influence of GABA and GABA-like drugs on brain monoamine metabolism. In: Advances in Biochemical Psychopharmacology, pp. 471-475. Eds. Costa, E. and G. L. Gessa. Raven Press: New York.
14. Cash, C. D. (1994) Gamma hydroxybutyrate: an overview of the pros and cons for its being a neuro-transmitter and/or a useful therapeutic agent. Neurosci Biobehav. Rev. 18, 291-304.
15. Clifford, J. M., Taberner, P. V., Tunnicliff, G., Rick, J. T. and Kerkut, G. A. (1973) Biochemical and pharmacological actions of imidazoleacetic acid. Biochem. Pharmacol. 22, 535-542.
16. Crawford, J. M. and Curtis, D. R. (1964) The excitation and depression of mammalian neurons by amino acids. Brit. J. Pharmacol. 23, 313-329.
17. Da Prada, M. and Keller, H. H. (1976) Badofen and γ-hydroxybutyrate: Similar effects on cerebral dopamine neurons. Life Sci. 19, 1253-1264.
18. De Carolis, A. S. and Massotti, M. (1978) Electroencephalographic and behavioral investigations on "GABAergic" drugs: Muscimol, baclofen and sodium gamma-hydroxybutyrate. Implications on human epileptic studies. Prog. Neuropsychopharmacol. 2, 431-442.
19. DeFeudis, F. V. and Collier, B. (1970) Amino acids of brain and gamma-hydroxybutyrate-induced depression. Arch. int. Pharmacodyn. 187, 30-36.
20. Deskin, R., Seidler, F.J., Whitmore, W.L. and Slotkin, T.A. J. Neurochem. 36, 1683-1690.
21. Enna, S. J. and Maggi, A. (1979) Biochemical pharmacology of GABAergic agonists. Life Sci. 24, 1727-1737.
22. Gabor, R., Regunathan, S. and Sourkes, T. L. (1989) Central regulation of adrenal tyrosine hydroxylase: Interaction between dopamine and GABA systems. Neuropharmacology 28, 521-527.
23. Gessa, G. L., Vargiu, L., Crabai, F., Boero, C. C., Caboni, R. and Camba, R. (1966) Selective increase of brain dopamine induced by gamma-hydroxybutyrate. Life Sci. 5, 1921-1930.
24. Giambalvo, C. T. (1988) Protein kinase C and dopamine release II. Effect of dopamine acting drugs in vivo. Biochem. Pharmacol. 37, 4009-4017.
25. Giorguieff, M. F., Kernel, M. L., Glowinski, J. and Besson, M. J. (1978) Stimulation of dopamine release by GABA in rat striatal slices. Brain Res. 139, 115-230.
26. Harris, N. C., Webb, C. and Greenfield, S. A. (1989) The effects of gamma-hydroxybutyrate on the membrane properties of guinea pig pars compact neurons in the substantia nigra in vitro. Neuroscience 31, 363-370.
27. Hechler, V., Gobaille, S., Bourguignon, J. J. and Maitre, M. (1991) Extracellular events induced by γ-hydroxybutyrate in striatum: A microdialysis study. J. Neurochem. 56, 938-944.
28. Hechler, V., Mersel, M., Dreyfus, H. and Maitre, M. (1990) Effects of phospholipases, proteases and neuraminidase on γ-hydroxybutyrate binding sites. Mol. Cell. Biochem. 93, 87-94.
29. 3H]-hydroxybutyrate binding site as determined by quantitative autoradiography. J. Neurochem. 49, 1025-1032.
30. Hechler, V., Bourguignon, J. J., Wermuth, C. G., Mandel, P. and Maitre, M. (1985) Gamma-hydroxybutyrate uptake by rat brain striatal slices. Neurochem. Res. 10, 387-396.
31. Hedner, T., Hedner, J., Bergman, B., Iversen, K. and Jonason, J. (1983) Effects of GABA and some GABA analogs on respiratory regulation in the pre-term rabbit. Biol. Neonate 43, 134-145.
32. Hedner, J., Hedner, T., Jonason, J. and Lundberg, D. (1981) GABA-ergic mechanisms in central respiratory control in the anaesthetized rat. Naunyn Schmied. Arch. Pharmacol. 317, 315-320.
33. Hedner, T., Hedner, J., Iversen, K., Wessberg, P. and Lundborg, P. (1985) Gammahydroxybutyric acid: Central biochemical and behavioral effects in neonatal rats. Pharmacol. Biochem. Behav. 23, 185-189.
34. Hedner, J., Jonason, J. and Lundberg, D. (1980) Respiratory effects of gamma-hydroxybutyric acid in anesthetized rats. J. Neural Transmission 49, 179-186.
35. Hedner, J. and Lundborg, P. (1983) Effect of gamma-hydroxybutyric acid on serotonin synthesis, concentration and metabolism in the developing rat brain. J Neural Transmission 57, 39-48.
36. B sites in rat brain. Nature 290, 149-152.
37. Ikeda, M., Dohi, T. and Tsujimoto, A. (1982) Protection from local anaesthetic-induced convulsions by gamma-aminobutyric acid. Anaesthesiology 56, 365-368.
38. 3H]-dopamine release study J. Neurochem. 50, 1-6.
39. Iversen, L. L. and Johnston, G. A. R. (1971) GABA uptake in the rat central nervous system: Comparison of uptake in slices and homogenates and the effects of some inhibitors. J. Neurochem. 18, 1939-1959.
40. Jouany, J. M., Gerard, J., Broussolle, B., Reynier, M., Simone, R., Orsetti, A., Vermuth, C. and Baron, C. (1960) Pharmacologie comparee des sels d'acide butyrique et de l'acide 4-hydroxy-butyrique. Agressologie 1, 417-427.
41. Kaufman, E. E., Nelson, T., Miller, D. and Stadlan, N. (1988) Oxidation of gamma-hydroxybutyrate to succinic semialdehyde by a mitochondrial pyridine nucleotide-independent mechanism. J. Neurochem. 51, 1079-1084.
42. + -independent oxidoreductase. J. Biol. Chem. 256, 6890-6894.
43. Kelly, P. H. and Moore, K. E. (1978) Dopamine concentrations in the rat brain following injections into the substantia nigra of baclofen, γ-aminobutyric acid, γ-hydroxybutyric acid, apomorphine and amphetamine. Neuropharmacology 17, 169-174.
44. Klunk, W. E., Covey, D. F. and Ferrendelli, J. A. (1982) Anticonvulsant properties of α, γ and α,γ-substituted γ-butyrolactones. Mol. Pharmacol. 22, 438-443.
45. Kovalev, G. V. and Tiurenkov, I. N. (1989) The search for substances activating the GABAergic system. Farmakol. Toksicol. 52, 5-11.
46. Kozhechkin, S. N. (1980) Microiontophoretic study of the mechanism of action of γ-hydroxybutyric acid. Bull. Exp. Biol. Med. 88, 1293-1296.
47. Laborit, H., Jouany, J. M., Gerard, J. and Fabiani, F. (1960) Résumé d'une étude expérimentale et clinique sur un substrat métabolique à action centrale inhibitrice: le 4-hydroxybutyrate de Na. Presse méd. 68, 1867-1869.
48. 3H] gamma-aminobutyric acid (GABA) binding in the human brain. Brain Res. 163, 77-87.
49. Maitre, M., Rumigny, J. F., Cash, C. D. and Mandel, P. (1983) Subcellular distribution of γ-hydroxybutyrate binding sites in rat brain. Principal locations in the synaptosomal fraction. Biochem. Biophys. Res. Comm. 110, 262-265.
50. Maitre, M. and Mandel, P. (1984) γ-hydroxybutyrate, a putative neurotransmitter in the central nervous system. C.R. Acad. Sc. Paris 298, 341-345.
51. Margolis, R. K. (1969) The effect of γ-hydroxybutyric acid on amino acid levels in brain. Biochem. Pharmacol. 18, 1243-1246.
52. McGeer, P. L. and McGeer, E. G. (1989) Amino acid transmitters. In: Basic Neurochemistry: Molecular, Cellular and Medical Aspect, pp. 311-332. Eds. Siegel, G. J., B. W. Agranoff, R. W. Albers and P. B. Molinoff. Raven Press: New York.
53. McIntire, K. D., Cleary, J. and Weinfurter, S. (1988) Gamma-butyrolactone's discriminability and effect on low rates of level pressing by rats: alone and in coimbination with d-amphetamine and naloxone. Pharmacol. Biochem. Behav. 30, 45-53.
54. Meldrum, B. (1979). Convulsant drugs, anticonvulsants and GABA-mediated neuronal inhibition. In: GABA-neurotransmitters, pp. 340-405. Eds Krogsgaard-Larsen, P., J. Scheel-Kruger and H-Kofoed. Munksgaard Press: Copenhagen.
55. Mitoma, C. and Neubauer, S. E. (1968) Gamma-hydroxybutyrate and sleep. Experientia 24, 12-13.
56. Möhler, H., Patel, A. and Balazs, R. (1976) Gamma-hydroxybutyrate degradation in the brain in vivo: Negligible direct conversion to GABA. J. Neurochem. 27, 253-258.
57. Naarendorp, F. and Sieving, P. A. (1991) The scotopic threshold response of the cat ERG is suppressed selectively by GABA and glycine. Vision Res. 31, 1-15.
58. Nelson, T., Kaufman, E., Kline, J. and Sokoloff, L. (1981) The extraneuronal distribution of γ-hydroxybutyrate. J. Neurochem. 37, 1345-1348.
59. 3H-DA from perfused carp retina. Neuroscience 6, 1857-1865.
60. Olpe, H. R. and Koella, W. P. (1979) Inhibition of nigral and neocortical cells by γ-hydroxybutyrate: A microiontophoretic investigation. Eur. J. Pharmacol. 53, 359-364.
61. B sites in rat brain. Mol. Pharmacol. 19, 217-227.
62. Osono, I. and Davidoff, R. A. (1979) Gamma-hydroxybutyrate is not a GABA-mimetic agent in the spinal cord. Ann. Neurol. 6, 111-116.
63. Pericic, D., Eng, N. and Walters, J. R. (1978) Post-mortem and aminooxyacetic acid-induced accumulation of GABA: Effect of γ-butyrolactone and picrotoxin. J. Neurochem. 30, 767-773.
64. Ratomponirina, C., Hode, Y., Hechler, V. and Maitre, M. (1995) γ-hydroxybutyrate receptor binding in rat brain is inhibited by guaanyl nucleotides and pertussis toxin. Neurosci. Lett. 189, 51-53.
65. Roth, R. H. (1970) Formation and regional distribution of γ-hydroxybutyric acid in mammalian brain. Biochem. Pharmacol. 19, 3013-3019.
66. Roth, R. H. (1976) Striatal dopamine and gamma-hydroxybutyrate. Pharmacol. Ther. (B) 2, 71-88.
67. Roth, R. H. and Giarman, N. J. (1970) Natural occurrance of gamma-hydroxybutyrate in mammalian brain. Biochem. Pharmacol. 19, 1087-1093.
68. Roth, R. H. and Giarman, N. J. (1965) Preliminary report on the metabolism of gamma-butyrolactone and gamma-hydroxybutyric acid. Biochem. Pharmacol. 14, 177-178.
69. Roth, R. H. and Nowycky, M. C. (1977) Dopaminergic neurons: Effects elicited by γ-hydroxybutyric acid are reversed by picrotoxin. Biochem. Pharmacol. 26, 2079-2082.
70. Roth, R. H., Doherty, J. D. and Walters, J. R. (1980) Gamma hydroxybutyrate: a role in the regulation of dopaminergic neurons?. Brain Res. 189, 556-560.
71. Schmidt, C., Gobaille, S., Hechler, V., Schmitt, M., Bourguignon, J. and Maitre, M. (1991) Anti-sedative and anti-cataleptic properties of NCS-382, a gamma-hydroxybutyrate receptor antagonist. Eur. J. Pharmacol. 203, 393-397.
72. Scholes, N. W. (1975) Pharmacologic definition of neuronal components generating spontaneous and evoked potentials in the tectum of the chick: Effect of γ-hydroxybutyrate. J. Pharmacol. Exp. Ther. 153, 128-132.
73. A receptor complex in the rat cerebral cortex. Psychopharmacology 104, 351-355.
74. Sherman, A. O. and Gebhart, G. F. (1975) An evaluation of the analgesia induced by morphine and gamma-hydroxybutyrate. Arch. int. Pharmacodyn. Ther. 213, 195-199.
75. B-mediated mechanisms in experimental generalized absence seizures. Eur. J. Pharmacol. 213, 343-349.
76. Snead, O. C. (1991) The gamma-hydroxybutyrate model of absence seizures: Correlation of regional brain levels of gamma-hydroxybutyric acid and gamma-butyrolactone with spike wave discharges. Neuropharmacology 30, 161-167.
77. Snead, O. C. (1990) The ontogeny of GABAergic enhancement of the gamma-hydroxybutyrate model of generalized absence seizures. Epilepsia 31, 363-368.
78. B binding sites: relation to the development of experimental absence seizures. Brain Res. 659, 147-156.
79. A receptor function in the gamma-hydroxybutyrate model of generalized absence seizures. Neuropharmacology 32, 401-409.
80. Snead, O. C. and Liu, C. C. (1984) Gamma-hydroxybutyric acid binding sites in rat and human brain synaptosomal membranes. Biochem. Pharmacol. 16, 2587-2590.
81. Snead, O., Liu, C. and Bearden, L. (1982) Studies on the relation of gamma-hydroxybutyric acid to gamma-aminobutyric acid. Evidence that GABA is not the sole source for GHB in rat brain. Biochem. Pharmacol. 31, 3917-3923.
82. Snead, O. C. and Morley, B. J. (1981) Ontogeny of γ-hydroxybutyric acid I. Regional concentration in developing rat, monkey, and human brain. Dev. Brain Res. 1, 579-589.
83. Stransky, Z. (1972) Effect of gamma-butyrolactone on central GABA levels. Biologia 27, 735-738.
84. Tabakoff, B. and von Wartburg, J. P. (1975) Separation of aldehyde reductases and alcohol dehydrogenase from brain by affinity chromatography: Metabolism of succinic semialdehyde and ethanol. Biochem. Biophys. Res. Comm. 63, 957-966.
85. Takashi, B., Takaori, S., Sasa, M. and Shimamoto, K. (1967) Central action of γ-butyrolactone and γ-hydroxybutyrate. Jap. J. Pharmacol. 17, 30-45.
86. Tarakanov, I. A., Golovatiuk, E. A., Turskaia, E. R. and Safonov, V. A. (1993a) The development of periodic apneic breathing during the activation of the GABAergic system of the brain. Biull. Eksp. Biol. Med. 115, 583-587.
87. Tarakanov, I. A., Kryzhanovskiri, G. N. and Safonov, V. A. (1993b) The participation of the GABAergic system of the brain in shaping the breathing rhythm. Fiziol Zh Im I M Sechenova 79, 13-23.
88. Tolpyshev, B. A. (1980) Influence of GABA-ergic substances on the effects of caudate nucleus stimulation and amphetamine stereotyping in cats. Farmacol. Toksikol. 43, 140-144.
89. Uspensky, A. E., Listvina, V. P. and Tsybina, N. M. (1973) Comparative characteristics of sodium γ-hydroxybutyrate, some of its γ-substituted analogs and of sodium γ-hydroxybutyrate. Pharmacol. Toxicol. U.S.S.R. 36, 185-191.
90. Vayer, P., Gobaille, S., Mandel, P. and Maitre, M. (1987) 3′5′ cyclic-guanosine monophosphate increase in rat brain hippocampus after gamma-hydroxybutyrate administration. Prevention by valproate and naloxone. Life Sci. 41, 605-610.
91. Vayer, P., Ehrhardt, J. D., Gobaille, S., Mandel, P. and Maitre, M. (1988) Gamma hydroxybutyrate distribution and turnover rates in discrete brain regions of the rat. Neurochem. Int. 12, 53-59.
92. B antagonist CGP 35348 antagonizes the effects of baclofen. gamma-butyrolactone and HA 966 on rat striatal dopamine synthesis. Naunyn Schmied. Arch. Pharmacol. 343, 173-178.
93. Walters, J. R., Lakoski, J. M. and Eng, N. (1975) Effect of GABA-mimetic agents and inhibitors of GABA metabolism on the activity of substantia nigra (SN) dopamine (DA) neurons. Neurosci. Abstr. 4, 285.
94. Winter, J. C. (1981) The stimulus properties of γ-hydroxybutyrate, Psychopharmacology 73, 372-375.